Sirtex Medical Limited Company Profile (ASX:SRX)

About Sirtex Medical Limited (ASX:SRX)

Sirtex Medical Limited logoSirtex Medical Limited is a medical device company with primary objective of manufacturing and distributing liver cancer treatments utilizing small particle technology to markets in Asia-Pacific; Europe, the Middle East and Africa (EMEA), and North and South America. The Company's segments include Asia Pacific, Americas and EMEA. Its lead product is SIR-Spheres Y-90 resin microspheres, which is a targeted radioactive treatment for liver cancer. The treatment is called Selective Internal Radiation Therapy (SIRT) and consists of a minimally invasive surgical procedure performed by an interventional radiologist. The SIR-Spheres microspheres lodge in the small blood vessels of the tumor where they destroy it from the inside while sparing the surrounding healthy tissue. The Company is also engaged in conducting other studies, which include SIRFLOX and FOXFIRE Global for liver metastases, and RESIRT for primary renal cell carcinoma. SIR-Spheres is available in over 40 countries.

Industry, Sector and Symbol:
  • Sector: N/A
  • Industry: N/A
  • Sub-Industry: N/A
  • Symbol: ASX:SRX
  • CUSIP: N/A
  • Web: www.sirtex.com/ap/
Average Prices:
  • 50 Day Moving Avg: A$14.33
  • 200 Day Moving Avg: A$15.27
P/E:
  • Trailing P/E Ratio: 19.59
  • P/E Growth: 2.60
Dividend:
  • Dividend Yield: 1.0%
Profitability:
  • Net Margins: 18.45%
  • Return on Equity: 21.04%
  • Return on Assets: 15.89%
 
Frequently Asked Questions for Sirtex Medical Limited (ASX:SRX)

What is Sirtex Medical Limited's stock symbol?

Sirtex Medical Limited trades on the ASX under the ticker symbol "SRX."

Who are some of Sirtex Medical Limited's key competitors?

Who are Sirtex Medical Limited's key executives?

Sirtex Medical Limited's management team includes the folowing people:

  • Andrew McLean, Chief Executive Officer, Executive Director
  • Darren Smith CPA, Chief Financial Officer, Company Secretary
  • Rueben Teo, Chief Executive Officer, Asia Pacific (APAC)
  • David Cade, Chief Medical Officer
  • Robert Hardie, Global Head - Operations
  • Nigel Lange, Chief Commercial Officer
  • Richard James Hill, Non-Executive Independent Chairman
  • John Eady Ph.D., Non-Executive Independent Deputy Chairman of the Board
  • Grant D. Boyce, Non-Executive Independent Director
  • Neville J. Mitchell, Independent Non-Executive Director


MarketBeat Community Rating for Sirtex Medical Limited (ASX SRX)
Community Ranking:  0.7 out of 5 ()
Outperform Votes:  5 (Vote Outperform)
Underperform Votes:  33 (Vote Underperform)
Total Votes:  38
MarketBeat's community ratings are surveys of what our community members think about Sirtex Medical Limited and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Sirtex Medical Limited (ASX:SRX) (How are Consensus Ratings Calculated?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for Sirtex Medical Limited (ASX:SRX)
Show:
No equities research coverage for this company has been tracked by MarketBeat.com

Earnings

Earnings History for Sirtex Medical Limited (ASX:SRX)
No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Earnings Estimates for Sirtex Medical Limited (ASX:SRX)

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Sirtex Medical Limited (ASX:SRX)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Sirtex Medical Limited (ASX:SRX)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Headline Trends for Sirtex Medical Limited (ASX:SRX)
Latest Headlines for Sirtex Medical Limited (ASX:SRX)
Source:
DateHeadline
finance.yahoo.com logoNew Analysis Reveals First-Line Treatment Data on SIR-Spheres® Y-90 Resin Microspheres for Patients with Liver Metastases from Right-Sided Primary Colon Cancer
finance.yahoo.com - July 4 at 7:37 AM
fool.com logoSome badly-needed good news for Sirtex Medical Limited shareholders
www.fool.com.au - July 3 at 1:54 AM
finance.yahoo.com logoSirtex Medical Ltd. – Value Analysis (ASX:SRX) : June 30, 2017
finance.yahoo.com - July 1 at 7:47 AM
fool.com logoWhy these 4 ASX shares are posting strong gains today - Motley Fool Australia
www.fool.com.au - June 29 at 7:00 AM
fool.com logoUp 39% in a month: The Sirtex Medical Limited share price is soaring - Motley Fool Australia
www.fool.com.au - June 29 at 7:00 AM
finance.yahoo.com logoSirtex Medical Ltd. breached its 50 day moving average in a Bullish Manner : SRX-AU : June 29, 2017
finance.yahoo.com - June 29 at 7:00 AM
fool.com logoWhy the Sirtex Medical Limited share price is climbing higher
www.fool.com.au - June 28 at 1:05 AM
fool.com logoShould you sell your shares for the tax loss? - Motley Fool Australia
www.fool.com.au - June 19 at 9:25 AM
finance.yahoo.com logoSIR-Spheres® Y-90 Resin Microspheres Showed No Significant Difference in Overall Survival (OS) Compared to Sorafenib in Advanced HCC with Significantly Fewer Severe Adverse Events, New Asia-Pacific Study Finds
finance.yahoo.com - June 5 at 11:39 AM
fool.com logoWhy the Sirtex Medical Limited share price is climbing higher today
www.fool.com.au - May 28 at 9:01 PM
fool.com logoSirtex Medical Limited shares fall as it gives market update - Motley Fool Australia
www.fool.com.au - May 24 at 9:08 AM
finance.yahoo.com logoMetastatic Colorectal Cancer Patients Treated First-line With SIR-Spheres® Y-90 Resin Microspheres More Likely to Become Candidates for Potentially Curative Liver Surgery, REsect Study Shows
finance.yahoo.com - May 24 at 9:08 AM
finance.yahoo.com logoMetastatic Colorectal Cancer Patients Treated First-line with SIR-Spheres(R) Y-90 Resin Microspheres More Likely to Become Candidates for Potentially Curative Liver Surgery, REsect Study Shows
finance.yahoo.com - May 24 at 9:08 AM
fool.com logoWhy these 4 ASX shares have been crushed today | Motley Fool ... - Motley Fool Australia
www.fool.com.au - May 18 at 12:57 PM
businesswire.com logoSirtex Medical Inc. Provides Update on SIR-Spheres® Y-90 Resin Microspheres in Combination with First-Line ... - Business Wire (press release)
www.businesswire.com - May 18 at 12:57 PM
finance.yahoo.com logoSirtex Medical Inc. Provides Update on SIR-Spheres® Y-90 Resin Microspheres in Combination with First-Line Chemotherapy for Patients with Unresectable Metastatic Colorectal Cancer (mCRC)
finance.yahoo.com - May 18 at 12:57 PM
fool.com logoTrading halt: Sirtex Medical Limited shares freeze pending market update - Motley Fool Australia
www.fool.com.au - May 17 at 7:56 PM
fool.com logoWhy Sirtex Medical Limited is among 4 shares getting hammered today - Motley Fool Australia
www.fool.com.au - April 25 at 9:40 AM
fool.com logoThe Sirtex Medical Limited share price is tumbling on SARAH trial disappointment
www.fool.com.au - April 24 at 11:22 AM
finance.yahoo.com logoSIR-Spheres® Y-90 Resin Microspheres Substantially Improves Quality of Survival in Primary Liver Cancer, New Study Against Standard Treatment Shows
finance.yahoo.com - April 24 at 11:22 AM
finance.yahoo.com logoSIR-Spheres(R) Y-90 Resin Microspheres Substantially Improves Quality of Survival in Primary Liver Cancer, New Study Against Standard Treatment Shows
finance.yahoo.com - April 24 at 11:22 AM
finance.yahoo.com logoSirtex Medical Ltd. – Value Analysis (ASX:SRX) : April 20, 2017
finance.yahoo.com - April 20 at 8:05 PM
finance.yahoo.com logoETFs with exposure to Sirtex Medical Ltd. : April 19, 2017
finance.yahoo.com - April 19 at 8:00 PM
fool.com logoWhy Oil Search Limited is among 4 shares getting slammed today
www.fool.com.au - April 19 at 9:06 AM
finance.yahoo.com logoSirtex Medical Ltd. breached its 50 day moving average in a Bearish Manner : SRX-AU : April 19, 2017
finance.yahoo.com - April 19 at 9:06 AM
fool.com logoBHP in the spotlight on Tuesday: 9 shares you need to watch today
www.fool.com.au - April 11 at 9:28 AM
finance.yahoo.com logoETFs with exposure to Sirtex Medical Ltd. : April 7, 2017
finance.yahoo.com - April 7 at 10:15 PM
fool.com logoDumped: Blackmores (ASX:BKL) and Sirtex (ASX:SRX) exit the ... - Motley Fool Australia
www.fool.com.au - March 10 at 8:03 AM
businesswire.com logoSynergy Radiology Associates Expands Treatment Options for Patients with Colon Cancer That Has Spread to the Liver
www.businesswire.com - March 3 at 7:59 PM
fool.com logoRESULT: Is Sirtex Medical Limited a jaw-dropping BARGAIN?
www.fool.com.au - February 23 at 1:14 AM
fool.com logoSee you in court: Why Sirtex Medical Limited is coming out fighting
www.fool.com.au - February 13 at 12:54 AM
fool.com logoSirtex Medical Limited facing more trouble with proposed compensation claims
www.fool.com.au - February 1 at 6:19 AM
fool.com logoWhy I'm long Sirtex Medical Limited shares - Motley Fool Australia
www.fool.com.au - January 25 at 6:12 AM
fool.com logoASX 200 plunges: 9 shares you should have been watching - Motley Fool Australia
www.fool.com.au - January 23 at 8:24 AM
fool.com logoPrimary Health Care Limited loses CEO: Should you buy? - Motley Fool Australia
www.fool.com.au - January 16 at 1:12 PM
fool.com logoSACKED & there could be trouble ahead for Sirtex Medical Limited - Motley Fool Australia
www.fool.com.au - January 16 at 1:12 PM
fool.com logoASX 200 to rebound: 8 shares you need to watch today
www.fool.com.au - January 15 at 7:27 PM
reuters.com logoBRIEF-Sirtex Medical terminates Gilman Wong as CEO
www.reuters.com - January 14 at 6:23 AM
fool.com logoAussie shares go NOWHERE as investors holiday - Motley Fool Australia
www.fool.com.au - January 4 at 3:09 AM
fool.com logoShould you worry about CEO share selling? - Motley Fool Australia
www.fool.com.au - December 23 at 4:19 AM
fool.com logoSirtex Medical Limited CEO takes leave as it investigates share selling
www.fool.com.au - December 20 at 7:52 PM
fool.com logoPlease Explain: Sirtex Medical Limited hit with query from the ASX - Motley Fool Australia
www.fool.com.au - December 15 at 5:55 AM
fool.com logoHow Bellamy’s and Sirtex Medical Limited show the importance of diversification
www.fool.com.au - December 12 at 8:04 PM
finance.yahoo.com logoNCCN Guidelines® Recommend SIR-Spheres® Y-90 Resin microspheres for the Treatment of Metastatic Colorectal Cancer
finance.yahoo.com - December 12 at 8:04 PM
fool.com logoFill up your XMAS stocking with these 3 bargain buys - Motley Fool Australia
www.fool.com.au - December 7 at 8:30 AM
fool.com logoWhy these 4 Aussie shares are getting THUMPED today - Motley Fool Australia
www.fool.com.au - November 30 at 10:36 AM
fool.com logoSirtex Medical Limited flags Histone program as multi-billion dollar opportunity
www.fool.com.au - November 29 at 3:33 PM
fool.com logoSirtex Medical Limited flags Histone program as multi-billion dollar opportunity - Motley Fool Australia
www.fool.com.au - November 28 at 5:58 PM
fool.com logo2 long-term growth stocks for the intelligent investor
www.fool.com.au - November 22 at 7:49 PM
fool.com logoBull v Bear: Sirtex Medical Limited boss sells $2 million worth of shares
www.fool.com.au - November 2 at 11:15 AM

Social

Social activity is not available for this stock.
This page was last updated on 7/23/2017 by MarketBeat.com Staff